BEVERLY, Mass., Sept. 5 /PRNewswire/ -- Hamilton Thorne Biosciences, Inc.,
a privately-held DNA technology company, will be presenting at the Emerging
Medical Technology Conference East at the Hyatt Regency in Cambridge, MA, on
September 6 at 9:10 AM.
Dr. Harry G. McCoy, President and COO of Hamilton Thorne Biosciences, will
present proprietary techniques in existence and under development that provide
easy-to-use and cost-effective DNA analysis for clinical and research
settings. These highly sensitive techniques rapidly identify the presence of
target nucleic acid sequences, whether a sample holds one cell or thousands.
The technology has applications for enabling more accurate detection in
microarrays, microfluidics, in situ biology and general clinical diagnostics.
Hamilton Thorne Biosciences is a recognized provider of analytical
instrumentation and reagents. The Company also has technologies that allow
breakthrough genomic and proteomic capabilities and gene-based diagnostics to
the drug discovery, infectious disease, cancer and women's healthcare markets.
One of their core DNA technologies, Ramification Amplification MethodTM,
provides super-exponential multiplication of target gene sequences, resulting
in the creation of billions of copies of the sequence for easy identification.
RAM(TM) operates at an isothermal temperature and can improve discrimination
power by 100 to 1000 fold over current technologies. Another DNA technology,
HSAM, Hybridization Signal Amplification Method(TM), enables the Company's
testing system to analyze nucleic acids, proteins and other small molecules.
Using a second core technology, QuantiLyse, Hamilton Thorne Biosciences
aims to become the leader in user-friendly, gene-based analysis of single
cells and quantification of rare biological events, such as the first
detectable recurrence of cancer cells. Hamilton Thorne Biosciences, Inc.
seeks investments to advance its technology platform and to develop its first
diagnostic products.
Additional information about the company and its technologies is available
at http://www.hamiltonthorne.com.
For more information contact:
Meg D. Hamilton, CEO
Hamilton Thorne Biosciences, Inc.
978-921-2050
http://www.hamiltonthorne.com
SOURCE Hamilton Thorne Biosciences, Inc.
 back to top
Related links:
http://www.hamiltonthorne.com
CONTACT:
Meg D. Hamilton, CEO of Hamilton Thorne
Biosciences, Inc., +1-978-921-2050
|
